
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cenova Capital, established in 2010, is headquartered in Shanghai, China. It is recognized as one of the earliest venture capital firms dedicated exclusively to the healthcare and life sciences sectors. The firm has played a significant role in the evolution of China's healthcare system, focusing on enhancing healthcare services, diagnostics, medical devices, and pharmaceuticals. Cenova Capital has built a reputation as a key player in the investment landscape, particularly in the context of healthcare innovation.
Currently, Cenova Capital manages five funds and has a diverse portfolio of over 50 companies. The firm has attracted investments from various limited partners, including Asian sovereign wealth funds, government institutions, insurance companies, financial institutions, and multinational corporations. Notable milestones include the successful exit of Folding Space Ltd. through an acquisition, showcasing the firm's ability to identify and nurture high-potential companies in the healthcare sector.
Cenova Capital specializes in early and growth-stage investments within the life sciences and healthcare sectors in China. The firm is particularly interested in companies that are innovating in healthcare services, diagnostics, medical devices, pharmaceuticals, and digital health. Cenova Capital's investment strategy aligns with its broader goal of facilitating the transition of China's healthcare system towards a more market-oriented model.
The firm seeks to partner with founders who demonstrate a strong vision and capability to drive innovation in healthcare. Cenova Capital prefers to invest in companies that have a clear path to growth and can navigate the complexities of the healthcare market in China. The firm typically engages in co-investment opportunities, leveraging its extensive network to support portfolio companies effectively.
Cenova Capital's portfolio includes over 50 companies across its five funds, showcasing a diverse range of investments in the healthcare sector. Notable companies in their portfolio include:
Additionally, Cenova Capital achieved a notable exit with Folding Space Ltd., which was sold as part of YSB Inc.'s acquisition for approximately CNY 800 million. This exit highlights the firm's ability to identify and support high-growth companies within the healthcare landscape.
Startups interested in pitching to Cenova Capital should reach out through a warm introduction whenever possible. The pitch deck should include a comprehensive overview of the business model, market analysis, competitive landscape, and financial projections. While there is no specific application form mentioned, a well-structured presentation is crucial.
Response times may vary, but founders should expect to hear back within a few weeks after submitting their pitch. Cenova Capital encourages clear and concise communication to facilitate the evaluation process.
Recent activity from Cenova Capital includes leading a $30 million Series B investment in Weimai, a healthcare big data platform, and participating in a CNY 280 million Series A financing round for Therorna. Additionally, the firm successfully exited its investment in Folding Space Ltd., which was sold as part of YSB Inc.'s acquisition for approximately CNY 800 million. These activities highlight Cenova Capital's ongoing engagement in the healthcare venture capital space in China.
What are Cenova Capital's investment criteria?
Cenova Capital focuses on early and growth-stage companies in the healthcare and life sciences sectors. The firm looks for innovative solutions that can enhance the healthcare system in China.
How can startups apply or pitch to Cenova Capital?
Startups interested in pitching to Cenova Capital should prepare a detailed presentation that outlines their business model, market potential, and growth strategy. A warm introduction is preferred, but cold outreach is also accepted.
What makes Cenova Capital different from other venture firms?
Cenova Capital is one of the earliest dedicated healthcare-focused venture capital firms in China, providing deep industry expertise and a strong network within the healthcare sector. This unique positioning allows them to offer valuable insights and support to portfolio companies.
What is the geographic scope of Cenova Capital's investments?
The firm primarily invests in companies based in China, focusing on the healthcare and life sciences sectors. Their expertise in the local market dynamics enhances their investment strategy.
What is Cenova Capital's approach to post-investment involvement?
Cenova Capital actively engages with its portfolio companies, providing strategic guidance and support to help them navigate the complexities of the healthcare market in China. This involvement is crucial for facilitating growth and innovation.
What is the typical check size for investments made by Cenova Capital?
While specific check sizes are not disclosed, Cenova Capital invests in early and growth-stage companies, indicating a range that aligns with the funding needs of startups in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.